Search Results 1441-1450 of 42110 for oral

1. Drugs and Supplements that Start with P - Mayo Clinic

   Pa · Pacaps. Also known as. Butalbital, acetaminophen, and caffeine (oral route) · Pacerone. Also known as. Amiodarone (oral route) · PACLitaxel. Also known as.

2. Methsuximide (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (capsules):. For seizures: Adults, teenagers, and children—At first, 300 milligrams (mg) once a day. Your doctor may increase your dose ...

3. Mitapivat (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For hemolytic anemia in patients with pyruvate kinase (PK) deficiency: Adults—At first, 5 milligrams (mg) 2 times a day ...

4. Levamlodipine (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For high blood pressure: Adults—At first, 2.5 milligrams (mg) once a day. Some patients may be started on 1.25 mg once a day ...

5. Peanut allergen-dnfp (oral route) - Mayo Clinic

   For oral dosage form (capsule, powder):. For decreasing severity of peanut allergy reaction: Children 4 to 17 years of age—There are three different phases ...

6. Meprobamate and aspirin (oral route) - Side effects & dosage - Mayo Clinic

   Adults—Oral, 1 or 2 tablets three or four times a day, as needed. Children up to 12 years of age: Use is not recommended. Storage. Store the medicine in a ...

7. Vandetanib (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For medullary thyroid cancer: Adults—300 milligrams (mg) once a day. Your doctor may adjust your dose as needed and ...

8. Emtricitabine and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For treatment of HIV infection: Adults and children weighing at least 35 kilograms (kg) and with creatinine clearance ...

9. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   The purpose of this study is to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

10. A Study Investigating Oral Ozanimod (RPC1063) In Pediatric Participants With Moderate To Severe Active Ulcerative Colitis - Mayo Clinic

    A Study Investigating Oral Ozanimod (RPC1063) In Pediatric Participants With Moderate To Severe Active Ulcerative Colitis · Overview · Participation eligibility.